Brightseed Bio is a technology company.
Brightseed Bio has raised $68.0M across 1 funding round.
Brightseed Bio has raised $68.0M in total across 1 funding round.
Brightseed Bio is a biosciences company leveraging AI to discover bioactive compounds from nature for human health applications. It builds Forager®, an AI platform that maps natural compounds to health benefits like gut health, weight management, and cognitive support, accelerating discovery from years to months.[1][2][3][4] The company serves food, beverage, dietary supplement, and consumer health industries by developing ingredients such as Brightseed Bio 01™, an upcycled hemp-based fiber with bioactives NCT and NFT for gut barrier support, and Bio Gut Core for digestive health.[1][4][6] Brightseed solves the challenge of the "dark matter" of nutrition—over 99% of bioactives remain undiscovered—by identifying millions of compounds and validating them through preclinical and clinical trials.[2][3][4] Growth includes mapping 40x more plant compounds than published literature, launching commercial products in 2022, and partnerships across the health continuum.[1][4]
Brightseed was co-founded by James Flatt (CEO and President), Sofia Elizondo (COO), and Lee Chae (CTO), with Elizondo highlighting the company's focus on computational bioactive discovery.[1][7] The idea emerged from advancements in computational biology, addressing the limitations in identifying nature's bioactives for health.[2] Forager® was developed to mine vast datasets from plants, microbes, and fungi, using high-resolution omics, robotics, and machine learning.[3] Early traction came from discovering NCT and NFT in hemp hulls for gut health, leading to the 2022 launch of Brightseed Bio 01™ and preclinical validations supporting gut barrier integrity.[1][2][3][4]
Brightseed rides the AI-for-biology wave, merging computational biology with nutrition science to unlock nature's untapped bioactives amid rising demand for natural, functional foods and personalized health.[2][4] Timing aligns with post-pandemic focus on gut microbiome, preventive wellness, and sustainable ingredients, as consumers seek evidence-based alternatives to synthetics.[1][6] Market forces like nutraceuticals growth and hemp upcycling favor it, with Forager enabling scalable solutions for food scarcity and health challenges.[1][3] It influences the ecosystem by partnering with CPG firms, advancing clinical insights, and inspiring AI-driven biotech for microbiome and longevity trends.[1][4]
Brightseed is poised to expand its bioactive portfolio into high-demand areas like sleep, stress, and metabolic health, with Forager's growing library fueling more discoveries and clinical trials.[2][3] Trends in AI-accelerated drug and nutrition discovery, alongside microbiome therapeutics, will amplify its momentum, potentially through deeper CPG integrations or pharma collaborations.[1][4] Its influence may evolve by standardizing bioactive mapping, bridging nature and precision health to redefine functional ingredients. This positions Brightseed as a key illuminator of nutrition's hidden potential, restoring human health one compound at a time.[4]
Brightseed Bio has raised $68.0M in total across 1 funding round.
Brightseed Bio's investors include Breakthrough Energy Ventures, Germin8 Ventures, Helium-3 Ventures, Matt Bellamy.
Brightseed Bio has raised $68.0M across 1 funding round. Most recently, it raised $68.0M Series B in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2022 | $68.0M Series B | Breakthrough Energy Ventures, Germin8 Ventures, Helium-3 Ventures, Matt Bellamy |